Advanced HIV Infection in Treatment-Naïve Individuals: Effectiveness and Persistence of Recommended 3-Drug Regimens.

Mounzer, Karam; Brunet, Laurence; Fusco, Jennifer S; Mcnicholl, Ian R; Diaz Cuervo, Helena; Sension, Michael; Mccurdy, Lewis; Fusco, Gregory P

Mounzer, Karam; Brunet, Laurence; Fusco, Jennifer S; Mcnicholl, Ian R; Diaz Cuervo, Helena; Sension, Michael; Mccurdy, Lewis; Fusco, Gregory P.

Afiliação

Mounzer K; Philadelphia FIGHT, Philadelphia, Pennsylvania, USA.
Brunet L; Epividian, Durham, North Carolina, USA.
Fusco JS; Epividian, Durham, North Carolina, USA.
Mcnicholl IR; Gilead Sciences, Inc., Foster City, California, USA.
Diaz Cuervo H; No current affiliation, Barcelona, Spain.
Sension M; CAN Community Health, Ft. Lauderdale, Florida, USA.
Mccurdy L; Atrium Health, Charlotte, North Carolina, USA.
Fusco GP; Epividian, Durham, North Carolina, USA.

Open Forum Infect Dis ; 9(3): ofac018, 2022 Mar.

Article em En | MEDLINE | ID: mdl-35169590

Palavras-chave

advanced HIV; antiretroviral therapy; cohort; discontinuation; effectiveness; late presenters

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Open Forum Infect Dis Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google